Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$3.57bn172.52n/a
au flag iconMSBMesoblastAU$3.24bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$986.92mn/an/a
au flag iconPYCPYC TherapeuticsAU$938.28mn/an/a
au flag iconIMMImmutepAU$576.85mn/an/a
au flag iconRACRacura OncologyAU$387.45mn/an/a
au flag iconCGSCogstateAU$363.19m25.980.87%
au flag iconDXBDimerixAU$302.25mn/an/a
au flag iconTTXTetratherixAU$200.82mn/an/a
au flag iconNYRNyradaAU$177.17mn/an/a
au flag iconACWActinogen MedicalAU$142.97mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$118.78mn/an/a
au flag iconALAArovella TherapeuticsAU$102.22mn/an/a
au flag iconLTPLtr PharmaAU$98.63mn/an/a
au flag iconILAIsland PharmaceuticalsAU$92.08mn/an/a
au flag iconBXNBioxyneAU$84.43m17.11n/a
au flag iconPIQProteomics International LaboratoriesAU$76.86mn/an/a
au flag iconCYPCynata TherapeuticsAU$72.31mn/an/a
au flag iconATXAmplia TherapeuticsAU$66.70mn/an/a
au flag iconATHAlterity TherapeuticsAU$63.89mn/an/a